Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. District Court for the Northern District of California denied Amgens motions seeking …

    Published on 3/23/2015
  • Biogen Idec, Eli Lilly, GlaxoSmithKline, J&J, Pfizer, Alzheimers Research UK, U.K. Department of Health neurology news

    Biogen Idec Inc.(NASDAQ:BIIB), Cambridge, Mass. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Pfizer Inc. (NYSE:…

    Published on 3/23/2015
  • Discovery Laboratories pulmonary news

    Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Discovery Laboratories disclosed in its 2014 financial results that it will restructure to focus on development of Aerosurf aerosolized KL4…

    Published on 3/23/2015
  • Enzo, Thermo Fisher genomics news

    Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Business: Genomics The U.S. Court of Appeals for the Federal Circuit (CAFC) vacated a lower court judgment that …

    Published on 3/23/2015
  • Amgen cancer news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Cancer Amgen will close the headquarters of its cancer-focused Onyx Pharmaceuticals Inc. subsidiary in South San Francisco, California, and lay off about 300 of …

    Published on 3/16/2015
  • BioMarin, Sanofi, Duke University endocrine/metabolic news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Duke University, Durham, N.C. Business: Endocrine/Metabolic The U.S. Patent and Trademark Offices Patent Trial …

    Published on 3/16/2015
  • Canon other news

    Canon Inc. (Tokyo:7751; NYSE:CAJ), Tokyo, Japan Business: Other Canon established Canon BioMedical Inc., a wholly owned subsidiary to serve as a headquarters for its biomedical business. The subsidiary will develop and …

    Published on 3/16/2015
  • Celltrion, Hospira, J&J, New York University autoimmune, biosimilars news

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. New York University, New York, N.Y. Business: Autoimmune, Biosimilars …

    Published on 3/16/2015
  • Merck pharmaceuticals news

    Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Merck discontinued discovery and non-clinical operations at its Cubist Pharmaceuticals Inc. subsidiary in Lexington, Massachusetts. The …

    Published on 3/16/2015
  • Mitsubishi Tanabe Pharma, U.S. Department of Health and Human Services infectious news

    Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded…

    Published on 3/16/2015
  • IDRI, U.S. Department of Health and Human Services infectious news

    Infectious Disease Research Institute (IDRI), Seattle, Wash. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious IDRI said HHSs Biomedical Advanced Research and Development Authority (…

    Published on 3/9/2015
  • J&J other, pharmaceuticals news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Other, Pharmaceuticals Johnson & Johnson launched the fourth incubator in its JLABS network, located in South San Francisco, and named the first 10 companies …

    Published on 3/9/2015
  • VaxInnate, U.S. Department of Health and Human Services infectious news

    VaxInnate Corp., Cranbury, N.J. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious VaxInnate said HHSs Biomedical Advanced Research and Development Authority (BARDA) modified and …

    Published on 3/9/2015
  • Amgen, Bayer, Mylan generics news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Generics Bayer and Onyx Pharmaceuticals Inc., now part of Amgen, filed suit …

    Published on 3/2/2015
  • Amgen, Novartis, Business: Biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. generics unit filed an opposition in the U.S. District Court for the …

    Published on 3/2/2015
  • Ariad, Sarissa Capital Management L.P. cancer news

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Sarissa Capital Management L.P., Greenwich, Conn. Business: Cancer Sarissa Capital launched a proxy battle to force Harvey Berger, Ariads principle founder, …

    Published on 3/2/2015
  • AstraZeneca infectious news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Infectious AstraZeneca said it will invest $40 million to spin out its early stage antibiotics unit in Waltham, Mass., into an unnamed subsidiary. The spinouts…

    Published on 3/2/2015
  • Bio-Reference Laboratories, Myriad Genetics diagnostic news

    Bio-Reference Laboratories Inc. (NASDAQ:BRLI), Elmwood Park, N.J. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic Myriad and Bio-References GeneDx Inc. subsidiary reached a settlement to …

    Published on 3/2/2015
  • Celimmune autoimmune, cancer news

    Celimmune LLC, Bethesda, Md. Business: Autoimmune, Cancer Newco Celimmune launched to acquire, develop and commercialize therapeutics to treat and prevent immune disorders. The company will initially focus on diet non-…

    Published on 3/2/2015
  • Pfizer infectious, cancer news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Infectious, Cancer Pfizer said it will cut an undisclosed number of R&D jobs at its Cambridge, Mass., and Collegeville, Pa., facilities. Pfizer declined to disclose which…

    Published on 3/2/2015
  • R-Tech Ueno, Sucampo, Par Pharmaceutical ophthalmic news

    R-Tech Ueno Ltd. (JASDAQ:4573), Tokyo, Japan Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Bethesda, Md. Par Pharmaceutical Cos. Inc., Woodcliff Lake, N.J. Business: Ophthalmic The companies said that in limited …

    Published on 3/2/2015
  • Spectrum Pharmaceuticals, Novartis cancer news

    Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cancer The U.S. District Court for the District of Nevada ruled that Spectrums U.S. Patent No. …

    Published on 3/2/2015
  • Teva, Actavis, Apotex, AstraZeneca, Novartis inflammation news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Actavis Inc. (NYSE:ACT), Parsippany, N.J. Apotex Inc., Toronto, Ontario AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Novartis AG (NYSE:NVS; SIX:…

    Published on 3/2/2015
  • The Foundation for AIDS Research infectious news

    The Foundation for AIDS Research (amfAR), New York, N.Y. Business: Infectious amfAR pledged $20 million to establish the amfAR Institute for HIV Cure Research, an academic center dedicated to curative research, and will…

    Published on 3/2/2015
  • AstraZeneca pl pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pharmaceuticals AstraZeneca agreed to pay the U.S. government $7.9 million to settle allegations that it engaged in a kickback scheme with Medco Health …

    Published on 2/23/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993